Phase 2 MIRA primary analysis trial results (12-week) for
Phase 2 MIRA primary analysis trial results (12-week) for MoonLake’s Nanobody® sonelokimab in hidradenitis suppurativa to be presented at a late-breaking...
Source: globenewswire.com
Hidradenitis Suppurative News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hidradenitis Suppurative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hidradenitis Suppurative Today - Breaking & Trending Today
Patients With Hidradenitis Suppurative Face Many Barriers When Accessing Care, Says Dr Haley Naik
Some of the many barriers patients with hidradenitis suppurative (HS) face include accessing knowledgeable providers, insurance coverage of treatment, and the way the health care system is set up, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
Source: ajmc.com
Dr Haley Naik Discusses Using Biologics and the Drug Pipeline for Hidradenitis Suppurativa
There are certain considerations when choosing which patient is the best fit for a biologic to treat hidradenitis suppurativa, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
Source: ajmc.com